You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EBV (associated)-T/NK-lymphoproliferative disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

Recruiting
  • LGLL - Large Granular Lymphocytic Leukemia
  • +13 more
  • Duarte, California
  • +9 more
Aug 9, 2022

Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

Recruiting
  • Hodgkin's Disease
  • +3 more
  • EBV-specific T cells: A
  • EBV-specific T cells: B
  • Houston, Texas
  • +1 more
Jun 28, 2022

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

Not yet recruiting
  • EBV Lymphoma
  • Post-transplant Lymphoproliferative Disease (PTLD)
  • Donor-derived ex-vivo expanded EBV Tscm CTL
  • Basel, Switzerland
  • +7 more
Jan 25, 2023

EBV-Related Hodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Non-Hodgkin's Lymphoma Trial in Houston (Dose Level 1A:

Not yet recruiting
  • EBV-Related Hodgkin Lymphoma
  • +2 more
  • Dose Level 1A: 2 x 10^7 cells/m2
  • +4 more
  • Houston, Texas
  • +1 more
Feb 7, 2022

Epstein-Barr Virus Infection moniToring in renAl Transplant

Recruiting
  • EBV Infection
  • +3 more
  • EBV DNA in whole blood and plasma
  • Aarhus, Central Region Denmark, Denmark
  • +2 more
Dec 12, 2022

Epstein-Barr Virus Associated Lymphoproliferative Disorder, EBV-Related PTLD, EBV Related Non-Hodgkin's Lymphoma Trial in

Recruiting
  • Epstein-Barr Virus Associated Lymphoproliferative Disorder
  • +7 more
  • Nanatinostat in combination with valganciclovir
  • Birmingham, Alabama
  • +57 more
Aug 10, 2022

EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Trial in Korea,

Recruiting
  • EBV Associated Extranodal NK/T-cell Lymphoma
  • EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
  • EBViNT Cell
  • Seoul, Gangnam-gu, Korea, Republic of
  • +7 more
Jul 7, 2022

Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

Available
  • Epstein-Barr Virus (EBV) Infections
  • +11 more
  • tabelecleucel
  • (no location specified)
Feb 15, 2022

Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

Recruiting
  • Epstein-Barr Virus (EBV)-Associated Diseases
  • +13 more
  • Tabelecleucel
  • Los Angeles, California
  • +39 more
Nov 9, 2022

NonHodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Lymphoma Trial in Houston (EBVST Cells, Nivolumab)

Completed
  • NonHodgkin Lymphoma
  • +6 more
  • EBVST Cells
  • Nivolumab
  • Houston, Texas
  • +1 more
Jul 19, 2021

Lymphoma Trial in Philadelphia (Pembrolizumab)

Withdrawn
  • Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 5, 2021

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Terminated
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
Aug 30, 2021

Extranodal NK/T-cell Lymphoma Trial in Korea, Republic of (VT-EBV-N, Placebo)

Recruiting
  • Extranodal NK/T-cell Lymphoma
  • VT-EBV-N
  • Placebo
  • Busan, Korea, Republic of
  • +7 more
Apr 28, 2022

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

Recruiting
  • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
  • +4 more
  • tabelecleucel
  • Duarte, California
  • +70 more
Jun 23, 2022

Genetic Studies of Chronic Active Epstein-Barr Disease

Recruiting
  • Chronic Active Epstein-Barr Virus
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • PK Blood Collection
    • +2 more
    • (no location specified)
    Nov 1, 2022

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +20 more
    • Scottsdale, Arizona
    • +1 more
    May 6, 2022

    Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

    Completed
    • Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
    • +2 more
    • tabelecleucel
    • La Jolla, California
    • +26 more
    Mar 24, 2021

    EBV-induced Lymphomas, EBV-associated Malignancies, Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent

    Completed
    • EBV-induced Lymphomas
    • +2 more
    • allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 21, 2020

    NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen

    Not yet recruiting
    • NK-T-Cell Lymphoma, Extranodal
    • 4 cycles of ESA regimen with sandwiched radiotherapy
    • +2 more
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Sep 29, 2023

    CLL, SLL, HCL Trial in Dresden

    Recruiting
    • CLL
    • +7 more
      • Dresden, Sachsen, Germany
        BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
      Apr 29, 2022

      Prognosis and Therapeutic Decision Tool for Autoimmunity and

      Not yet recruiting
      • Autoimmune Lymphoproliferative Syndrome
      • +19 more
      • Collection of samples
      • (no location specified)
      May 26, 2021